LeadIQ logo
Learn more at LeadIQ.com

Insights

Strategic Partnerships Genesis Therapeutics has recently entered into strategic collaborations with industry giants like Gilead Sciences and NVIDIA, indicating potential partnership and sales opportunities to explore synergies in discovering novel therapies.

Substantial Funding With over $280M in funding from top investors such as Andreessen Horowitz and T. Rowe Price, Genesis Therapeutics has the financial backing to invest in cutting-edge technologies and solutions, providing sales opportunities for innovative products and services.

Advanced AI Platform The use of the proprietary and advanced AI platform, GEMS, enables Genesis Therapeutics to accelerate drug discovery processes. Companies offering AI-driven solutions or services can explore sales opportunities by enhancing Genesis's capabilities further.

Rapid Team Growth Genesis Therapeutics is rapidly expanding its team, indicating increasing research and development activities. Sales professionals can leverage this growth to position their products or services that cater to the evolving needs of the biotechnology and AI sector.

Market Expansion Recent news highlights Genesis Therapeutics' focus on expanding its market presence through strategic collaborations and funding rounds. This expansion presents sales opportunities for companies looking to engage with a growing player in the biotechnology research industry.

Similar companies to Genesis Therapeutics

Genesis Therapeutics Tech Stack

Genesis Therapeutics uses 8 technology products and services including Cloudflare CDN, Google Workspace, Google Cloud, and more. Explore Genesis Therapeutics's tech stack below.

  • Cloudflare CDN
    Content Delivery Network
  • Google Workspace
    Email
  • Google Cloud
    Infrastructure As A Service
  • jQuery
    Javascript Libraries
  • HTTP/3
    Miscellaneous
  • Google
    Miscellaneous
  • Open Graph
    Miscellaneous
  • Python
    Programming Languages

Media & News

Genesis Therapeutics's Email Address Formats

Genesis Therapeutics uses at least 1 format(s):
Genesis Therapeutics Email FormatsExamplePercentage
First@genesistherapeutics.aiJohn@genesistherapeutics.ai
76%
FLast@genesistherapeutics.aiJDoe@genesistherapeutics.ai
20%
FL@genesistherapeutics.aiJD@genesistherapeutics.ai
3%
Middle@genesistherapeutics.aiMichael@genesistherapeutics.ai
1%

Frequently Asked Questions

Where is Genesis Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Genesis Therapeutics's main headquarters is located at Chapin Ave Burlingame, California 94010 US. The company has employees across 2 continents, including North AmericaSouth America.

What is Genesis Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Genesis Therapeutics's official website is genesistherapeutics.ai and has social profiles on LinkedIn.

How much revenue does Genesis Therapeutics generate?

Minus sign iconPlus sign icon
As of August 2024, Genesis Therapeutics's annual revenue reached $15M.

What is Genesis Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Genesis Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Genesis Therapeutics have currently?

Minus sign iconPlus sign icon
As of August 2024, Genesis Therapeutics has approximately 100 employees across 2 continents, including North AmericaSouth America. Key team members include Chief Scientific Officer: S. P.Chief Medical Officer: L. N.Head Of People, Sr. Director: I. H. W.. Explore Genesis Therapeutics's employee directory with LeadIQ.

What industry does Genesis Therapeutics belong to?

Minus sign iconPlus sign icon
Genesis Therapeutics operates in the Biotechnology Research industry.

What technology does Genesis Therapeutics use?

Minus sign iconPlus sign icon
Genesis Therapeutics's tech stack includes Cloudflare CDNGoogle WorkspaceGoogle CloudjQueryHTTP/3GoogleOpen GraphPython.

What is Genesis Therapeutics's email format?

Minus sign iconPlus sign icon
Genesis Therapeutics's email format typically follows the pattern of . Find more Genesis Therapeutics email formats with LeadIQ.

How much funding has Genesis Therapeutics raised to date?

Minus sign iconPlus sign icon
As of August 2024, Genesis Therapeutics has raised $200M in funding. The last funding round occurred on Aug 21, 2023 for $200M.
Genesis Therapeutics

Genesis Therapeutics

Biotechnology ResearchCalifornia, United States51-200 Employees

Genesis Therapeutics – headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego – is unifying AI and biotechnology to discover novel and breakthrough treatments for patients with severe and devastating conditions. We are using a proprietary state-of-the-art generative and predictive AI platform called GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery.

The GEMS platform integrates deep learning-based predictive models, molecular simulations, and molecular generative AI. GEMS accelerates hit ID through lead optimization and candidate selection by generating promising molecules for synthesis and experimental testing, and iterating this process through multiple cycles of AI-enabled discovery and optimization. 

We have leveraged GEMS to build an internal pipeline with multiple programs against high-value targets, including data-poor and canonically undruggable targets where GEMS is uniquely advantaged. In addition, Genesis has two AI platform collaborations across a range of therapeutic areas: Eli Lilly (signed in 2022) and Genentech (signed in 2020).

Genesis has raised over $280M in funding from top technology and biotech investors, including Andreessen Horowitz, Rock Springs Capital, T. Rowe Price, Fidelity, Radical Ventures, NVentures (NVIDIA's VC arm), BlackRock, and Menlo Ventures. We are rapidly growing our team with a variety of openings on our machine learning, computational chemistry, and software teams (primarily located in the Bay Area) and our chemistry, biology, and clinical teams (primarily located in San Diego). To learn more about Genesis Therapeutics, or current employment opportunities, please visit our website.

Section iconCompany Overview

Headquarters
Chapin Ave Burlingame, California 94010 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $200M

    Genesis Therapeutics has raised a total of $200M of funding over 5 rounds. Their latest funding round was raised on Aug 21, 2023 in the amount of $200M.

  • $10M$50M

    Genesis Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $200M

    Genesis Therapeutics has raised a total of $200M of funding over 5 rounds. Their latest funding round was raised on Aug 21, 2023 in the amount of $200M.

  • $10M$50M

    Genesis Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.